Nova Eye Medical Limited (ASX:EYE)
Australia flag Australia · Delayed Price · Currency is AUD
0.1700
-0.0050 (-2.86%)
Feb 5, 2026, 3:53 PM AEST

Nova Eye Medical Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
5.066.157.42817.8
Cash & Short-Term Investments
5.066.157.42817.8
Cash Growth
-17.82%-17.09%-7.26%-55.06%-81.39%
Accounts Receivable
4.093.91.932.051.91
Other Receivables
0.090.181.181.723.52
Receivables
4.184.083.113.775.43
Inventory
2.814.283.813.542.9
Prepaid Expenses
0.270.230.270.280.2
Total Current Assets
12.3314.7514.615.5926.33
Property, Plant & Equipment
3.363.92.362.953.51
Other Intangible Assets
6.867.038.457.173.44
Long-Term Deferred Charges
3.894.134.8710.858.66
Other Long-Term Assets
0.070.070.070.070.06
Total Assets
26.529.8830.3636.6341.99
Accounts Payable
2.353.574.312.412
Accrued Expenses
2.171.641.320.910.74
Current Portion of Long-Term Debt
----1.42
Current Portion of Leases
0.630.480.640.540.52
Other Current Liabilities
--0.010.010
Total Current Liabilities
5.155.686.273.864.69
Long-Term Leases
2.382.870.891.41.76
Long-Term Deferred Tax Liabilities
---0.970.14
Other Long-Term Liabilities
----0.08
Total Liabilities
7.548.557.176.236.66
Common Stock
58.9452.7145.1837.4436.68
Retained Earnings
-39.75-30.69-21.9-6.60.89
Comprehensive Income & Other
-0.23-0.69-0.09-0.44-2.24
Shareholders' Equity
18.9721.3323.1930.435.34
Total Liabilities & Equity
26.529.8830.3636.6341.99
Total Debt
3.023.351.531.943.7
Net Cash (Debt)
2.042.85.896.0614.1
Net Cash Growth
-27.27%-52.41%-2.79%-57.05%-84.72%
Net Cash Per Share
0.010.010.040.040.10
Filing Date Shares Outstanding
284.71229.06190.33145.58143.69
Total Common Shares Outstanding
284.15228.82190.33145.58143.69
Working Capital
7.179.078.3311.7321.64
Book Value Per Share
0.070.090.120.210.25
Tangible Book Value
12.1114.314.7423.2231.89
Tangible Book Value Per Share
0.040.060.080.160.22
Machinery
3.483.072.962.562.32
Source: S&P Global Market Intelligence. Standard template. Financial Sources.